Get the Stockscreener App
78.92
0.52%
0.41
Revolution Medicines Inc stock is traded at $78.92, with a volume of 2.16M.
It is up +0.52% in the last 24 hours and up +19.88% over the past month.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
See More
Previous Close:
$78.51
Open:
$78.85
24h Volume:
2.16M
Relative Volume:
0.96
Market Cap:
$15.26B
Revenue:
$29.52M
Net Income/Loss:
$-567.06M
P/E Ratio:
-21.56
EPS:
-3.66
Net Cash Flow:
$-551.11M
1W Performance:
-0.90%
1M Performance:
+19.88%
6M Performance:
+91.97%
1Y Performance:
+75.65%
1-Day Range:
$78.05
$80.44
1-Week Range:
$77.31
$81.49
52-Week Range:
$29.17
$81.49
Revolution Medicines Inc Stock (RVMD) Company Profile
Name
Revolution Medicines Inc
Sector
Industry
Phone
415-766-3638
Address
700 SAGINAW DR, REDWOOD CITY, CA
Compare RVMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
78.92 | 15.18B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-25 | Initiated | Wolfe Research | Outperform |
| Nov-03-25 | Initiated | RBC Capital Mkts | Outperform |
| Oct-21-25 | Initiated | Mizuho | Outperform |
| Oct-16-25 | Resumed | Stifel | Buy |
| Sep-12-25 | Resumed | Raymond James | Strong Buy |
| Sep-05-25 | Initiated | Truist | Buy |
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Aug-15-25 | Initiated | Wells Fargo | Overweight |
| Jul-15-25 | Initiated | Goldman | Buy |
| Jul-16-24 | Reiterated | Needham | Buy |
| Jul-12-24 | Initiated | Barclays | Overweight |
| Jul-08-24 | Initiated | Jefferies | Buy |
| Apr-12-24 | Reiterated | Needham | Buy |
| Apr-10-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-11-24 | Initiated | Piper Sandler | Overweight |
| Jan-05-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-04-24 | Initiated | Wedbush | Outperform |
| Nov-16-23 | Initiated | Raymond James | Outperform |
| Feb-28-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-14-22 | Initiated | Needham | Buy |
| Oct-21-22 | Initiated | Oppenheimer | Outperform |
| May-20-22 | Initiated | BofA Securities | Neutral |
| Mar-01-22 | Upgrade | Stifel | Hold → Buy |
| Sep-23-21 | Initiated | Stifel | Hold |
| Aug-12-21 | Downgrade | Goldman | Buy → Neutral |
| May-18-21 | Initiated | Goldman | Buy |
| May-21-20 | Initiated | H.C. Wainwright | Buy |
| Mar-09-20 | Initiated | Cowen | Outperform |
| Mar-09-20 | Initiated | Guggenheim | Buy |
| Mar-09-20 | Initiated | JP Morgan | Neutral |
View All
Revolution Medicines Inc Stock (RVMD) Latest News
Avoiding Lag: Real-Time Signals in (RVMD) Movement - news.stocktradersdaily.com
Delphia Therapeutics Appoints Steve Kelsey, M.D., To Board - citybiz
Revolution Medicines (NASDAQ:RVMD) Reaches New 1-Year HighStill a Buy? - MarketBeat
Revolution Medicines (NASDAQ:RVMD) Nasdaq Today Therapeutic Shift - Kalkine Media
Revolution Medicines, Inc. $RVMD Shares Sold by Hood River Capital Management LLC - MarketBeat
New York State Common Retirement Fund Grows Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Norges Bank Invests $62.58 Million in Revolution Medicines, Inc. $RVMD - MarketBeat
State Board of Administration of Florida Retirement System Acquires 30,128 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines (RVMD) Up 27.9% Since Last Earnings Report: Can It Continue? - sharewise.com
Will Revolution Medicines Inc. Equity Warrant stock split attract more investors2025 Retail Activity & Weekly High Momentum Picks - Newser
Why Revolution Medicines Inc. Equity Warrant stock is favored by pension fundsJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - Newser
Russell Investments Group Ltd. Sells 86,034 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines (NASDAQ:RVMD) Hits New 52-Week HighShould You Buy? - MarketBeat
Why hedge funds are buying Revolution Medicines Inc. Equity Warrant stock2025 AllTime Highs & Free Daily Entry Point Trade Alerts - Newser
Rhumbline Advisers Reduces Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines stock hits all-time high at 78.2 USD By Investing.com - Investing.com South Africa
Revolution Medicines stock hits all-time high at 78.2 USD - Investing.com
TD Cowen reiterates Buy rating on Revolution stock, sees $5B+ opportunity - Investing.com UK
American Century Companies Inc. Has $16.72 Million Stock Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Will Revolution Medicines Inc. (42Z) stock outperform value peers - Newser
Is Revolution Medicines Inc. (42Z) stock a contrarian opportunityAnalyst Downgrade & Fast Entry High Yield Stock Tips - Newser
Why Revolution Medicines Inc. stock could rally in 20252025 Big Picture & Real-Time Stock Entry Alerts - Newser
Franklin Resources Inc. Takes $9.26 Million Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Discipline and Rules-Based Execution in RVMD Response - news.stocktradersdaily.com
Swiss National Bank Cuts Stock Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Is Revolution Medicines Inc Equity Warrant a good long term investmentFinancial Sector Performance & Market Trend Real-Time Reports - earlytimes.in
Revolution Medicines, Inc. $RVMD Shares Sold by JPMorgan Chase & Co. - MarketBeat
Jefferies Financial Group Inc. Trims Stake in Revolution Medicines, Inc. $RVMD - MarketBeat
Mark Goldsmith Sells 60,000 Shares of Revolution Medicines (NASDAQ:RVMD) Stock - MarketBeat
XTX Topco Ltd Grows Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Insider Sell: Jack Anders Sells Shares of Revolution Medicines I - GuruFocus
[Form 4] Revolution Medicines, Inc. Insider Trading Activity - Stock Titan
CFO Anders Sells 5,418 ($400.9K) Of Revolution Medicines Inc [RVMD] - TradingView
Universal Beteiligungs und Servicegesellschaft mbH Buys 5,060 Shares of Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. $RVMD Shares Sold by Magnetar Financial LLC - MarketBeat
Chmn Goldsmith Files To Sell 60,000 Of Revolution Medicines Inc [RVMD] - TradingView
Shareholder Goldsmith J Files To Sell 3,000 Of Revolution Medicines Inc [RVMD] - TradingView
Revolution Medicines (NASDAQ:RVMD) Reaches New 52-Week HighHere's What Happened - MarketBeat
Creative Planning Has $2.42 Million Stake in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. $RVMD Shares Sold by ProShare Advisors LLC - MarketBeat
AXQ Capital LP Takes $282,000 Position in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines stock hits all-time high at 72.76 USD By Investing.com - Investing.com Nigeria
Revolution Medicines stock hits all-time high at 72.76 USD - Investing.com
Revolution Medicines IncOrdinary Shares (RVMD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
CapEx per share of Revolution Medicines, Inc. – BX:RVMD - TradingView
Revolution Medicines, Inc. $RVMD Shares Sold by Ensign Peak Advisors Inc - MarketBeat
Dynamic Technology Lab Private Ltd Has $801,000 Stock Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Westfield Capital Management Co. LP Increases Holdings in Revolution Medicines, Inc. $RVMD - MarketBeat
Neo Ivy Capital Management Invests $1.14 Million in Revolution Medicines, Inc. $RVMD - MarketBeat
Revolution Medicines, Inc. $RVMD Shares Sold by Geode Capital Management LLC - MarketBeat
Revolution Medicines Inc Stock (RVMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):